{
  "id": 6900782,
  "title": "Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness",
  "url": "https://urgent.news/2026/09/12/heart-disease-a-historic-strength-for-big-pharma-becomes-a-weakness",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-12T09:30:00.000Z",
  "source": {
    "name": "WSJ Markets",
    "slug": "wsj-markets",
    "url": "https://www.wsj.com/health/pharma/heart-disease-a-historic-strength-for-big-pharma-becomes-a-weakness-983f0062?mod=rss_markets_main"
  },
  "original_language": "en",
  "account": null,
  "summary": "Heart disease remains humanity’s top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make money.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}